Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine
- DOI
- 10.1016/j.isci.2022.104771
- Published
- 2022-08
- Container
- iScience
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.isci.2022.104771,
title = {Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine},
author = {Despoina Aslanoglou and Suzanne Bertera and Laura Friggeri and Marta Sánchez-Soto and Jeongkyung Lee and Xiangning Xue and Ryan W. Logan and J. Robert Lane and Vijay K. Yechoor and Peter J. McCormick and Jens Meiler and R. Benjamin Free and David R. Sibley and Rita Bottino and Zachary Freyberg},
year = {2022},
journal = {iScience},
doi = {10.1016/j.isci.2022.104771},
url = {https://doi.org/10.1016/j.isci.2022.104771}
}RIS
TY - JOUR TI - Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine AU - Despoina Aslanoglou AU - Suzanne Bertera AU - Laura Friggeri AU - Marta Sánchez-Soto AU - Jeongkyung Lee AU - Xiangning Xue AU - Ryan W. Logan AU - J. Robert Lane AU - Vijay K. Yechoor AU - Peter J. McCormick AU - Jens Meiler AU - R. Benjamin Free AU - David R. Sibley AU - Rita Bottino AU - Zachary Freyberg PY - 2022 JO - iScience DO - 10.1016/j.isci.2022.104771 UR - https://doi.org/10.1016/j.isci.2022.104771 ER -
APA
Aslanoglou, D., Bertera, S., Friggeri, L., Sánchez-Soto, M., Lee, J., Xue, X., Logan, R. W., Lane, J. R., Yechoor, V. K., McCormick, P. J., Meiler, J., Free, R. B., Sibley, D. R., Bottino, R., & Freyberg, Z. (2022). Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine. iScience. https://doi.org/10.1016/j.isci.2022.104771
Source records
- crossref · retrieved 2026-09-27T03:46:38.720Z